Kuznetsov V F, Iushchuk N D, Iurko L P, Nabokova N Iu
Ter Arkh. 1994;66(11):17-8.
Intestinal dysbacteriosis was found in all 37 patients with intestinal yersiniosis or pseudotuberculosis. Administration of biopreparations containing lacto- or bifidobacteria produced a good clinico-microbiological response rate (above 90%). The authors think it valid to include biopreparations in combined treatment of yersiniosis to prevent unfavourable outcomes.
在所有37例肠道耶尔森菌病或假结核患者中均发现肠道菌群失调。给予含乳酸杆菌或双歧杆菌的生物制剂产生了良好的临床微生物学反应率（超过90%）。作者认为在耶尔森菌病的联合治疗中加入生物制剂以预防不良后果是有效的。
